Soleno Therapeutics (SLNO) Profit After Tax (QoQ) (2014 - 2026)
Soleno Therapeutics (SLNO) Profit After Tax (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.72% |
| Dec 31, 2025 | 66.89% |
| Sep 30, 2025 | 652.53% |
| Jun 30, 2025 | 89.24% |
| Mar 31, 2025 | 21.30% |
| Dec 31, 2024 | 27.40% |
| Sep 30, 2024 | -250.58% |
| Jun 30, 2024 | -2.13% |
| Mar 31, 2024 | -89.43% |
| Dec 31, 2023 | -4.00% |
| Sep 30, 2023 | -28.17% |
| Jun 30, 2023 | -1.42% |
| Mar 31, 2023 | -52.31% |
| Dec 31, 2022 | 10.53% |
| Sep 30, 2022 | 8.82% |
| Jun 30, 2022 | -17.49% |
| Mar 31, 2022 | -102.40% |
| Dec 31, 2021 | 65.26% |
| Sep 30, 2021 | 25.92% |
| Jun 30, 2021 | -22.72% |